This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Sales Leaders & Customers to Aid Nu Skin's (NUS) Q3 Earnings
by Zacks Equity Research
Nu Skin's (NUS) Q3 performance to gain from a sturdy base of sales leaders and customers. Projections for the impending quarter unveil a favorable picture.
Factors Likely to Influence Meredith's (MDP) Q1 Earnings
by Zacks Equity Research
While strategic buyouts and restructuring actions serve as key growth drivers for Meredith (MDP), soft EBITDA margins may be a deterrent.
Will Monster Beverage (MNST) Beat Earnings Estimates in Q3?
by Zacks Equity Research
Monster Beverage (MNST) benefits from product innovation strategy and regular product launches. Latest additions to the Monster brand are likely to generate incremental sales and boost profitability.
Can Keurig Dr Pepper (KDP) Deliver Earnings Beat in Q3?
by Zacks Equity Research
Keurig Dr Pepper (KDP) is poised to gain from DPS' distribution strategy and innovation alongside Keurig's coffee brands and online presence. But, soft CSD trends and higher aluminum prices are woes.
Why Turning Point Brands, Inc. (TPB) Could Beat Earnings Estimates Again
by Zacks Equity Research
Turning Point Brands, Inc. (TPB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Archer Daniels (ADM) Poised for Earnings Beat in Q3?
by Zacks Equity Research
Archer Daniels (ADM) saw a stellar start to 2018, having beaten earnings and sales in the first two quarters of 2018. Do strategies position it for a Q3 beat?
Medifast (MED) Q3 Earnings: Coaches & OPTAVIA are Key Drivers
by Zacks Equity Research
Medifast's (MED) Q3 performance to gain from a sturdy coach base and advancement in the OPTAVIA brand.
Turning Point Brands, Inc. (TPB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Turning Point Brands, Inc. (TPB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Influence Coca-Cola's (KO) Q3 Earnings
by Zacks Equity Research
Coca-Cola (KO) gains from the effective execution of strategies to evolve as a consumer-centric total beverage company.
Can AB InBev (BUD) Break Fall Even as Beer Brands Lose Fizz?
by Zacks Equity Research
AB InBev (BUD) suffers due to industry-wide decline in beer sales as consumers shift to healthier drinks. However, the company???s robust outlook indicates that there is an upside potential.
Altria (MO) in Focus: Stock Moves 6.7% Higher
by Zacks Equity Research
Altria (MO) was a big mover last session, as the company saw its rise nearly 7% on the day amid huge volumes.
Boston Beer (SAM) Surges Despite Beer Woes: Will it Persist?
by Zacks Equity Research
Boston Beer (SAM) rallies despite industry headwinds, including a soft beer category, a shift to healthier drinks and higher costs. The company's non-beer portfolio shows potential for further growth.
Has Turning Point Brands (TPB) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (TPB) Outperforming Other Consumer Staples Stocks This Year?
Turning Point Brands Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Turning Point Brands has been struggling lately, but the selling pressure may be coming to an end soon.
What's in Store for Keurig Dr Pepper (KDP) in Q2 Earnings? (Revised)
by Zacks Equity Research
Keurig Dr Pepper (KDP) to gain from Dr Pepper's strong distribution network and Keurig's online presence. However, industry-wide CSD category headwinds are likely to impact the company's volumes.
Turning Point Brands, Inc. (TPB) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Turning Point Brands, Inc. (TPB) delivered earnings and revenue surprises of 2.04% and 0.25%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Keurig Dr Pepper (KDP) in Q2 Earnings?
by Zacks Equity Research
Keurig Dr Pepper (KDP) to gain from Dr Pepper's strong distribution network and Keurig's online presence. However, industry-wide CSD category headwinds are likely to impact the company's volumes.
Soft Sales & Margin Trends to Hurt Newell's (NWL) Q2 Earnings
by Zacks Equity Research
Newell (NWL) struggles due to lower core sales, adverse pricing and commodity cost inflation. Soft sales forecast and weak margins make us apprehensive about the second quarter.
4 Stocks With Recent Price Strength to Enhance Your Returns
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
How Energizer Holdings (ENR) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Energizer Holding's (ENR) strategic acquisitions and product innovation efforts are likely to drive top-line growth in Q3, while strained margin and high debt may dent its bottom line.
Solid Organic Growth Aid Diageo's (DEO) Fiscal 2018 Earnings
by Zacks Equity Research
Diageo (DEO) delivers solid top- and bottom-line growth for the preliminary fiscal 2018, ended Jun 30, 2018, driven by strong organic sales and organic operating profit.
Boston Beer (SAM) Falls as Higher Costs Weigh on Q2 Earnings
by Zacks Equity Research
Boston Beer (SAM) delivers top- and bottom-line miss in second-quarter 2018, driven by higher costs and lower gross margins. It increases depletion and capex goals for 2018 and cuts gross margin view.
AB InBev (BUD) Tops on Q2 Earnings & Sales, Simplifies Zones
by Zacks Equity Research
AB InBev (BUD) delivers top and bottom line beat in second-quarter 2018, backed by improving trends in key markets, ongoing revenue management initiatives and strong performance of premium brands.
Zacks Industry Outlook Highlights: Philip Morris International, Altria Group, British American Tobacco, Imperial Tobacco Group and Turning Point Brands
by Zacks Equity Research
Zacks Industry Outlook Highlights: Philip Morris International, Altria Group, British American Tobacco, Imperial Tobacco Group and Turning Point Brands
Tobacco Industry Stock Outlook: Will RRPs Help Heal Burns?
by Zacks Equity Research
Stringent FDA regulations and fading demand for cigarettes plague the performance of most tobacco players. RRPs have been a life saver for a few.